The World Health Organisation (WHO), which recently issued a medical health alert against cough syrups manufactured by Indian firm Maiden Pharmaceuticals following the death of 66 children in Gambia, on October 29 informed the Drug Controller General of India (DGCI) that it collected 23 samples of medicines under reference for further testing and four samples were found to be contaminated with diethylene glycol/ ethylene glycol an ingredient which may have contributed to the death of the children.
The potentially fatal contaminant, which the World Health Organisation (WHO) yesterday flagged in four cough syrups manufactured by Sonepat-based Maiden Pharmaceuticals, had killed 12 infants in Udhampur, J&K, two years ago, leading to the closure of Kala Amb firm Digital Vision and its multiple
The Central Drugs Standard Control Organisation (CDSCO) has sent the samples of the same batch of the four Maiden Pharmaceuticals Ltd-manufactured medicines, on which the WHO issued alert,
Uniindia: Jalandhar, Oct 7 (UNI) Despite many ailments like regular cold and cough “being self-limiting and getting cured” on their own, the Indian pharmaceutical market is flooded with cough syrups and combination medication without any proven benefits. For a child’s cough, the best medicine is no medicine said Dr Naresh Purohit, Advisor - National Communicable Disease Control Programme.